![UCB’s VIMPAT[®] (lacosamide) CV now approved by FDA in U.S. for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy](/_up/ucb_com_presscenter/images/presscenter_teaser_12.jpg?300)
@Goddpzdefense Thank you for sharing your story. It is best to get care from a health care provider who specializes in treating inflammatory and rheumatic diseases. We can’t recommend a doctor but we suggest finding a rheumatologist in your area using this link: https://t.co/1M9bSYNe7E.
Top of this page
Skip navigation, go straight to the content
Newsroom
•
Overview
Newsroom
Press Release
Social Media
Twitter Feed
Resources
Access our media image selection or contact us for particular requests.
UCB on YouTube
Contact
The UCB media relations team responds to calls and emails from professional journalists only.